IRIDEX Corporation is a medical devices business based in the US. IRIDEX Corporation shares (IRIX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.59 – an increase of 8.16% over the previous week. IRIDEX Corporation employs 111 staff and has a trailing 12-month revenue of around $49.7 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.59 |
|---|---|
| 52-week range | $1.45 - $3.65 |
| 50-day moving average | $1.86 |
| 200-day moving average | $2.40 |
| Wall St. target price | $2.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.67 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.585 from 2024-10-15
| 1 week (2024-10-11) | 2.92% |
|---|---|
| 1 month (2024-09-18) | -17.02% |
| 3 months (2024-07-18) | -19.95% |
| 6 months (2024-04-18) | -47.52% |
| 1 year (2023-10-18) | -46.99% |
|---|---|
| 2 years (2022-10-18) | -34.50% |
| 3 years (2021-10-18) | 7.43 |
| 5 years (2019-10-18) | 1.87 |
| Revenue TTM | $49.7 million |
|---|---|
| Gross profit TTM | $25.4 million |
| Return on assets TTM | -19.61% |
| Return on equity TTM | -122.71% |
| Profit margin | -21.85% |
| Book value | $0.26 |
| Market Capitalization | $26.4 million |
TTM: trailing 12 months
We're not expecting IRIDEX Corporation to pay a dividend over the next 12 months.
Over the last 12 months, IRIDEX Corporation's shares have ranged in value from as little as $1.4508 up to $3.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRIDEX Corporation's is 0.79. This would suggest that IRIDEX Corporation's shares are less volatile than average (for this exchange).
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.